Navigation Links
DrugRisk Center Adds Latest on First of 3,000 Actos Bladder Cancer Trials

New York, NY (PRWEB) March 28, 2013

The prescription drug resource center is announcing new information to the site for those who have taken the medication Actos for diabetes. With drug maker Takeda facing claims from patients alleging bladder cancer, the first trial is underway in California.

The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the most up-to-date warnings, recalls, studies and legal news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.

The resource center contains warnings from experts such as the FDA and European Medicines Agency*, who have warned that long-term use of Actos may be associated with an increased bladder cancer risk. The drug has also been banned in France and Germany**.

Although Actos remains on the market in the United States, DrugRisk has learned that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer***. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

The resource center has added information from the first of these Actos lawsuit trials, which began this month in California for a retired man dying of bladder cancer***. A former pharmacologist for Takeda testified that, as news of bladder cancer risks spread, executives were more concerned with maintaining sales than the safety of patients***.

Anyone affected by bladder cancer after taking Actos is urged to contact DrugRisk or speak with a lawyer about their legal rights as soon as possible. Lawyers are still helping those affected file claims.

Due to the specialized nature of drug injury litigation, however, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.

To learn more about the studies linking Actos to bladder cancer, as well as Actos side effects and legal news, or to speak with a lawyer, visit today.

*; an_pha_detail_000033.jsp&mid=WC0b01ac058001d126
***; Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles).

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Announces Updated Information on Mirena Lawsuits
4. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
5. DrugRisk Announces New Pradaxa Health Warning From Australia
6. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
7. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
8. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
9. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
10. DrugRisk Update: Bayer Discloses $500 Million Remaining for Yaz Lawsuits
11. DrugRisk Update: Evidence Submitted in Actos Lawsuit Suggests Drug Maker Knew of Cancer Risks
Post Your Comments:
(Date:12/2/2015)... Southlake, Texas (PRWEB) , ... December 02, 2015 ... ... S. Reeves, M.D., and Eric J. Coligado, M.D., are both included in the ... of the annual Super Doctors® list, employs a rigorous, multi-step process to select ...
(Date:12/2/2015)... ... December 02, 2015 , ... The International Association ... February 17 - 21 at the Omni on Amelia Island, Florida, featuring nationally ... FAED, CEDS, a clinical psychologist who has specialized in eating disorders and related ...
(Date:12/2/2015)... ... 2015 , ... First Choice Emergency Room , the largest network of ... the Medical Director of its new Round Rock facility. , “We are pleased ... Rock location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:12/2/2015)... ... 2015 , ... First Choice Emergency Room , the largest network of ... as the Medical Director of its new Frisco- Eldorado facility. , “We are ... Frisco- Eldorado location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:12/2/2015)... ... December 02, 2015 , ... Accreditation for Cardiovascular ... Washington area have completed the process of ACE accreditation for cardiac catheterization and ... St. Joseph Medical Center in Tacoma, St. Anthony Hospital in Gig Harbor, and ...
Breaking Medicine News(10 mins):
(Date:12/2/2015)... ) has ... Market by Product Type, Surgery Type, End ... 2020"  report to their offering.  --> ... of the  "Spine Biologics Market by Product ... - Global Forecast to 2020"  report to ...
(Date:12/2/2015)... , December 2, 2015 /PRNewswire/ ... announced the addition of the  "Global ... their offering.  --> ... the  "Global Laparotomy Sponge Market 2015-2019" ... Research and Markets ( ) ...
(Date:12/1/2015)... , Dec. 1, 2015 As enforcement ... Supply Chain Security Act (DSCSA) approaches, InfiniTrak ... and independent pharmacies comply with looming FDA regulations. ... InfiniTrak is entering endorsement agreements with State Pharmacy ... services administration organization (PSAO) to exclusively provide the ...
Breaking Medicine Technology: